Bristol to Buy Stake in UniQure, Maker of $1 Million Drug

April 6, 2015 3:53 PM

54 0

Bristol-Myers Squibb Co. agreed to acquire a stake in UniQure NV, maker of the first $1 million drug, in a bet on the promise of gene therapy.

In the pact, Bristol-Myers will get access to UniQure’s proprietary therapy for congestive cardiac failure that’s intended to restore the heart’s ability to synthesize S100A1, a calcium sensor and master regulator of heart function. The companies will also work together on as many as nine additional...

Also read: Celgene quarterly revenue rises 28 percent as Revlimid shines

Read more

To category page